vs
Side-by-side financial comparison of RING ENERGY, INC. (REI) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RING ENERGY, INC. is the larger business by last-quarter revenue ($66.9M vs $57.3M, roughly 1.2× RHYTHM PHARMACEUTICALS, INC.). On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -19.8%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -15.9%).
Siemens Energy AG is a German publicly traded energy corporation formed through the spin-off of the former Gas and Power division of Siemens, and it includes full ownership of Siemens Gamesa.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
REI vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $66.9M | $57.3M |
| Net Profit | — | $-47.5M |
| Gross Margin | — | 91.6% |
| Operating Margin | -37.6% | -82.2% |
| Net Margin | — | -83.0% |
| Revenue YoY | -19.8% | 36.9% |
| Net Profit YoY | — | -9.6% |
| EPS (diluted) | $-0.07 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $66.9M | $57.3M | ||
| Q3 25 | $78.6M | $51.3M | ||
| Q2 25 | $82.6M | $48.5M | ||
| Q1 25 | $79.1M | $32.7M | ||
| Q4 24 | $83.4M | $41.8M | ||
| Q3 24 | $89.2M | $33.3M | ||
| Q2 24 | $99.1M | $29.1M | ||
| Q1 24 | $94.5M | $26.0M |
| Q4 25 | — | $-47.5M | ||
| Q3 25 | $-51.6M | $-52.9M | ||
| Q2 25 | $20.6M | $-46.6M | ||
| Q1 25 | $9.1M | $-49.5M | ||
| Q4 24 | — | $-43.3M | ||
| Q3 24 | $33.9M | $-43.6M | ||
| Q2 24 | $22.4M | $-32.3M | ||
| Q1 24 | $5.5M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | — | 89.9% | ||
| Q1 24 | — | 89.2% |
| Q4 25 | -37.6% | -82.2% | ||
| Q3 25 | -70.0% | -102.6% | ||
| Q2 25 | 28.4% | -93.4% | ||
| Q1 25 | 28.3% | -143.7% | ||
| Q4 24 | 28.3% | -98.6% | ||
| Q3 24 | 33.4% | -132.0% | ||
| Q2 24 | 42.2% | -139.2% | ||
| Q1 24 | 39.8% | -538.7% |
| Q4 25 | — | -83.0% | ||
| Q3 25 | -65.7% | -103.1% | ||
| Q2 25 | 25.0% | -96.1% | ||
| Q1 25 | 11.5% | -151.4% | ||
| Q4 24 | — | -103.6% | ||
| Q3 24 | 38.0% | -131.2% | ||
| Q2 24 | 22.6% | -110.9% | ||
| Q1 24 | 5.8% | -544.4% |
| Q4 25 | $-0.07 | $-0.73 | ||
| Q3 25 | $-0.25 | $-0.82 | ||
| Q2 25 | $0.10 | $-0.75 | ||
| Q1 25 | $0.05 | $-0.81 | ||
| Q4 24 | $0.03 | $-0.71 | ||
| Q3 24 | $0.17 | $-0.73 | ||
| Q2 24 | $0.11 | $-0.55 | ||
| Q1 24 | $0.03 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $902.9K | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $836.3M | $139.1M |
| Total Assets | $1.4B | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $902.9K | $388.9M | ||
| Q3 25 | $286.9K | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | $1.1M | $314.5M | ||
| Q4 24 | $1.9M | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | $1.2M | $319.1M | ||
| Q1 24 | $1.4M | $201.2M |
| Q4 25 | $836.3M | $139.1M | ||
| Q3 25 | $847.7M | $148.8M | ||
| Q2 25 | $897.9M | $-11.9M | ||
| Q1 25 | $876.0M | $18.9M | ||
| Q4 24 | $858.6M | $21.7M | ||
| Q3 24 | $851.3M | $11.2M | ||
| Q2 24 | $817.4M | $39.3M | ||
| Q1 24 | $793.0M | $61.6M |
| Q4 25 | $1.4B | $480.2M | ||
| Q3 25 | $1.4B | $506.9M | ||
| Q2 25 | $1.5B | $372.7M | ||
| Q1 25 | $1.5B | $386.7M | ||
| Q4 24 | $1.4B | $392.3M | ||
| Q3 24 | $1.4B | $363.6M | ||
| Q2 24 | $1.4B | $381.8M | ||
| Q1 24 | $1.4B | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $44.7M | $-25.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $44.7M | $-25.4M | ||
| Q3 25 | $44.5M | $-26.6M | ||
| Q2 25 | $33.3M | $-23.3M | ||
| Q1 25 | $28.4M | $-40.4M | ||
| Q4 24 | $47.3M | $-18.8M | ||
| Q3 24 | $51.3M | $-25.2M | ||
| Q2 24 | $50.6M | $-29.1M | ||
| Q1 24 | $45.2M | $-40.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.61× | — | ||
| Q1 25 | 3.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 2.26× | — | ||
| Q1 24 | 8.19× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
